| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |